C vs COLL
Citigroup Inc. (C) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
C currently screens at market cap $214.73B and trailing P/E 15.5. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the C and COLL stock pages for the full models.
Not investment advice.